Health Canada
Symbol of the Government of Canada
Drugs and Health Products

Consultation - Evaluation of Phase I of the Summary Basis of Decision Initiative

The online consultation is now closed. The content found on this page is a snapshot of the live consultation as it was presented to the public and contains the content that was open for submissions during the consultation period.

Transparency is a fundamental good regulatory practice and a clear expectation of the Canadian public. Health Canada is committed to enhancing the transparency of the regulatory review process for drugs and medical devices. The Summary Basis of Decision initiative was developed in 2004 in demonstration of this commitment to transparency. As part of the Summary Basis of Decision initiative, Health Canada publishes Notice of Decision and Summary Basis of Decision documents.

Health Canada is undertaking an evaluation of phase I of the Summary Basis of Decision initiative. As part of this evaluation, we are asking stakeholders to complete this workbook and submit it to OBT_enquiries@hc-sc.gc.ca by May 15, 2009.

How to Get Involved

The consultation workbook can be completed and submitted on-line starting April 7, 2009 until May 15, 2009 inclusive.

Consultation Workbook

Interested stakeholders are encouraged to complete and submit the consultation workbook by May 15, 2009.

If you have any questions, contact us at:

Office of Business Transformation

Phone: 613-941-1248
Fax: 613-957-1483
Email: obt_enquiries@hc-sc.gc.ca

Reporting to Canadians

The results of the evaluation of phase I of the Summary Basis of Decision initiative will be published on the Health Canada Web site in summer/fall 2009.